Our products

Our main objective is enabling Healthcare Professionals all over the world to make the most informed decisions so as to help the largest number of people.

PharmaMar Commercial Products

PharmaMar Commercial Products

"We are committed to bringing safe and efficacious medicines to people with unmet medical needs all over the world as quickly as possible."

Juan Nogués

International Marketing & Sales Director

Our Marketed Drugs

For over 30 years from its start in 1986, PharmaMar reinvested revenues or partnership income into R&D and building out the team.

TRABECTEDIN

Yondelis®

Treatment of patients with soft-tissue sarcoma and ovarian cancer.

LURBINECTEDIN

Zepzelca®

Treatment of patients with small cell lung cancer.

PLITIDEPSIN

Aplidin®

Treatment of multiple myeloma​.

WE'RE HERE TO HELP

Request more information about our marketed drug Yondelis

We have a clear goal in mind: to make our therapies available in the shortest possible time for all appropriate patients.

We work with Healthcare Professionals and Patients, collectively and as individuals, as the focal point of a partnership.

Request more information

Market Access at PharmaMar

Our goal is to make our therapies available in the shortest possible time for all appropriate patients.

Global Market Access at PharmaMar is involved, with achieving reimbursement, and access for our therapies.

Beatriz Garcia San Andres, Market Access Senior Manager.

Market Access at PharmaMar

"One of our values is rigor, by which we mean that we are prepared to carry out the development of our products consistently, with rigor to the scientific process, under the dictated specifications.

Another is accountability, by which we say that we are motivated to offer hope to patients with unmet medical needs, including in rare disease, and are accountable to patients as well as ourselves to deliver on this."

Carmen Cuevas

Director, R&D

SIDE EFFECTS AND ADVERSE EVENTS

Help us maintain the highest standards of safety

If you are aware of any side effect or adverse event for anyone including you or a loved one using one of our medicines, please report it immediately to us.

Who can communicate an adverse event?

Communicating side effects and adverse events is a shared responsibility, where everyone is a key actor.

Patients

Doctors

Nurses

Caregivers & Family

Pharmacist

Scientific Journals

Health Care Providers

Health Care Agencies

0.4429 seconds.